Gene · 2118
Papers2,714
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,714
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Three-Dimensional Genome Organization in Breast and Gynecological Cancers: How Chromatin Folding Influences Tumorigenic Transcriptional Programs. | Cells | 2021 | 35011637 | PubTator, text mining | PubMed |
| Mutational Characterization of Colorectal Cancer from Korean Patients with Targeted Sequencing. | J Cancer | 2021 | 35003350 | PubTator, text mining | PubMed |
| Insights Into Amentoflavone: A Natural Multifunctional Biflavonoid. | Front Pharmacol | 2021 | 35002708 | PubTator, text mining | PubMed |
| One oncogene, several vulnerabilities: EWS/FLI targeted therapies for Ewing sarcoma. | J Bone Oncol | 2021 | 34976713 | PubTator, text mining | PubMed |
| Human Endogenous Retroviruses as Gene Expression Regulators: Insights from Animal Models into Human Diseases. | Mol Cells | 2021 | 34963103 | PubTator, text mining | PubMed |
| Protective Effects and Benefits of Olive Oil and Its Extracts on Women's Health. | Nutrients | 2021 | 34959830 | PubTator, text mining | PubMed |
| Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies. | Front Immunol | 2021 | 34956172 | PubTator, text mining | PubMed |
| A Novel Circular RNA CircRFX3 Serves as a Sponge for MicroRNA-587 in Promoting Glioblastoma Progression via Regulating PDIA3. | Front Cell Dev Biol | 2021 | 34950658 | PubTator, text mining | PubMed |
| Epithelial-Mesenchymal Transition Signaling and Prostate Cancer Stem Cells: Emerging Biomarkers and Opportunities for Precision Therapeutics. | Genes (Basel) | 2021 | 34946849 | PubTator, text mining | PubMed |
| Somatic Mutational Profile of High-Grade Serous Ovarian Carcinoma and Triple-Negative Breast Carcinoma in Young and Elderly Patients: Similarities and Divergences. | Cells | 2021 | 34944094 | PubTator, text mining | PubMed |
| Crosstalk with keratinocytes causes GNAQ oncogene specificity in melanoma. | Elife | 2021 | 34939927 | PubTator, text mining | PubMed |
| Primary cardiac CIC-rearranged undifferentiated sarcoma in an infant. | Pediatr Investig | 2021 | 34938974 | PubTator, text mining | PubMed |
| Integrated multi-omics data reveals the molecular subtypes and guides the androgen receptor signalling inhibitor treatment of prostate cancer. | Clin Transl Med | 2021 | 34936729 | PubTator, text mining | PubMed |
| Novel Genes Potentially Involved in Fibroblasts of Diabetic Wound. | J Diabetes Res | 2021 | 34917686 | PubTator, text mining | PubMed |
| Epigenetic loss of heterogeneity from low to high grade localized prostate tumours. | Nat Commun | 2021 | 34911933 | PubTator, text mining | PubMed |
| Transcriptomics of single dose and repeated carbon black and ozone inhalation co-exposure highlight progressive pulmonary mitochondrial dysfunction. | Part Fibre Toxicol | 2021 | 34911549 | PubTator, text mining | PubMed |
| NUTM1-Rearranged Neoplasms-A Heterogeneous Group of Primitive Tumors with Expanding Spectrum of Histology and Molecular Alterations-An Updated Review. | Curr Oncol | 2021 | 34898574 | PubTator, text mining | PubMed |
| Regulation of positive and negative selection and TCR signaling during thymic T cell development by capicua. | Elife | 2021 | 34895467 | PubTator, text mining | PubMed |
| Molecular Alterations Associated with Acquired Drug Resistance during Combined Treatment with Encorafenib and Binimetinib in Melanoma Cell Lines. | Cancers (Basel) | 2021 | 34885166 | PubTator, text mining | PubMed |
| The Impact of Core Tissues on Successful Next-Generation Sequencing Analysis of Specimens Obtained through Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration. | Cancers (Basel) | 2021 | 34884991 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2118/papers?page=36